相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication
H. Shindo et al.
JOURNAL OF VIRAL HEPATITIS (2013)
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Ludmila Prokunina-Olsson et al.
NATURE GENETICS (2013)
Hepatic Cell-Type Specific Gene Expression Better Predicts HCV Treatment Outcome Than IL28B Genotype
Ian McGilvray et al.
GASTROENTEROLOGY (2012)
Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV
Norma I. Rallon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naive Patients With Chronic Hepatitis C
Albert Friedrich Staettermayer et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1
M. Lindh et al.
JOURNAL OF VIRAL HEPATITIS (2011)
IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study
Vijayaprakash Suppiah et al.
PLOS MEDICINE (2011)
Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
Andri Rauch et al.
GASTROENTEROLOGY (2010)
Interferon-Lambda: A New Addition to an Old Family
Raymond P. Donnelly et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Interferon Lambda as a Potential New Therapeutic for Hepatitis C
Dennis M. Miller et al.
CYTOKINE THERAPIES: NOVEL APPROACHES FOR CLINICAL INDICATIONS (2009)
IFN-λ1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells
Jihong Dai et al.
BLOOD (2009)
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines
K. Witte et al.
GENES AND IMMUNITY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Interleukin-29 Functions Cooperatively with Interferon to Induce Antiviral Gene Expression and Inhibit Hepatitis C Virus Replication
Nicole E. Pagliaccetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Interferon lambda-1 (IFN-λ1/IL-29) induces ELR- CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-γ-independent manner
V. Pekarek et al.
GENES AND IMMUNITY (2007)
Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda 1/IL-29)
W. J. Jordan et al.
GENES AND IMMUNITY (2007)
Interferon-λ-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells
Franck J. D. Mennechet et al.
BLOOD (2006)
Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus
Bo Chi et al.
JOURNAL OF VIROLOGY (2006)
Lambda interferon inhibits hepatitis B and C virus replication
MD Robek et al.
JOURNAL OF VIROLOGY (2005)
Interferon type I gene expression in chronic hepatitis C
S Mihm et al.
LABORATORY INVESTIGATION (2004)
Development of a standardized protocol for reproducible generation of matured monocyte-derived dendritic cells suitable for clinical application
HR Bohnenkamp et al.
CYTOTECHNOLOGY (2003)
IL-28, IL-29 and their class II cytokine receptor IL-28R
P Sheppard et al.
NATURE IMMUNOLOGY (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
分享论文
